{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:56:54Z","timestamp":1785419814689,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mental Health Research Institute of Victoria"},{"name":"Stanley Medical Research Foundation"},{"name":"MBF"},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001166","name":"Beyond Blue","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008068","name":"Geelong Medical Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008068","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008021","name":"Bristol Myers Squibb","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Eli Lilly"},{"name":"Glaxo SmithKline"},{"DOI":"10.13039\/100014369","name":"Organon","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014369","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mayne Pharma"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.pnpbp.2011.11.011","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T16:53:25Z","timestamp":1324659205000},"page":"132-135","source":"Crossref","is-referenced-by-count":27,"title":["Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder"],"prefix":"10.1016","volume":"37","author":[{"given":"P.V.","family":"Magalh\u00e3es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.M.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.I.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"Copolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Weisinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"Malhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jeavons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Schapkaitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Anderson-Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2011.11.011_bb0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/S1461145708009498","article-title":"Neuroprogression: pathways to progressive brain changes in bipolar disorder","volume":"12","author":"Berk","year":"2009","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.2004.00412.x","article-title":"Scale matters: the need for a Bipolar Depression Rating Scale (BDRS)","volume":"110","author":"Berk","year":"2004","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1016\/j.pnpbp.2011.11.011_bb0225","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1399-5618.2007.00536.x","article-title":"The Bipolar Depression Rating Scale (BDRS): its development, validation and utility","volume":"9","author":"Berk","year":"2007","journal-title":"Bipolar Disorder"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","article-title":"N-acetyl cysteine for depressive symptoms in bipolar disorder \u2014 a double-blind randomized placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jad.2007.06.011","article-title":"The empirical redefinition of the psychometric criteria for remission in bipolar disorder","volume":"106","author":"Berk","year":"2008","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0200","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tips.2008.05.001","article-title":"Glutathione: a novel treatment target in psychiatry","volume":"29","author":"Berk","year":"2008","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0205","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","author":"Berk","year":"2010"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0040","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1139\/Y08-090","article-title":"Comparative effects of N-acetyl-L-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats","volume":"86","author":"El Midaoui","year":"2008","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0045","first-page":"321","article-title":"Quality-of-life enjoyment and satisfaction questionnaire \u2014 a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/JCP.7075su1c.04","article-title":"The effects of undertreated chronic medical illnesses in patients with severe mental disorders","volume":"70","author":"Fagiolini","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0055","first-page":"93","article-title":"Insulin resistance and metabolic syndrome in outpatients with bipolar disorder","volume":"37","author":"Gomes","year":"2010","journal-title":"Revista De Psiquiatria Clinica"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0060","article-title":"Mediators of allostasis and systemic toxicity in bipolar disorder","author":"Grande","year":"2011","journal-title":"Physiology & Behavior"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11064-007-9466-y","article-title":"Effect of chronic N-acetyl cysteine administration on oxidative status in the presence and absence of induced oxidative stress in rat striatum","volume":"33","author":"Harvey","year":"2008","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0070","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00109-002-0406-7","article-title":"Improvement in muscular performance and decrease in tumor necrosis factor level in old age after antioxidant treatment","volume":"81","author":"Hauer","year":"2003","journal-title":"Journal of Molecular Medicine-Jmm"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0447.2008.01320.x","article-title":"Neurocognitive functions in euthymic bipolar patients","volume":"119","author":"Jamrozinski","year":"2009","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0080","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1192\/bjp.166.5.654","article-title":"A brief mental-health outcome scale \u2014 reliability and validity of the global assessment of functioning (GAF)","volume":"166","author":"Jones","year":"1995","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neubiorev.2007.10.005","article-title":"Allostatic load in bipolar disorder: implications for pathophysiology and treatment","volume":"32","author":"Kapczinski","year":"2008","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0085","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/mp.2009.112","article-title":"A systemic toxicity index developed to assess peripheral changes in mood episodes","volume":"15","author":"Kapczinski","year":"2010","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2011.11.011_bb0215","first-page":"156","article-title":"Teixeira AL, Magalhaes PV, Kauer-Sant'Anna M, Klamt F, et al","volume":"45","author":"Kapczinski","year":"2011","journal-title":"Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0105","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archpsyc.1987.01800180050009","article-title":"The longitudinal interval follow-up evaluation \u2014 a comprehensive method for assessing outcome in prospective longitudinal-studies","volume":"44","author":"Keller","year":"1987","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0110","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1176\/ps.2008.59.7.760","article-title":"Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial","volume":"59","author":"Kilbourne","year":"2008","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/pubmed\/23.3.179","article-title":"Estimating health needs: the impact of a checklist of conditions and quality of life measurement on health information derived from community surveys","volume":"23","author":"Knight","year":"2001","journal-title":"Journal of Public Health Medicine"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0125","doi-asserted-by":"crossref","first-page":"88-88","DOI":"10.1111\/j.1601-5215.2011.00530.x","article-title":"Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder","volume":"23","author":"Magalhaes","year":"2011","journal-title":"Acta Neuropsychiatrica"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jad.2010.08.001","article-title":"N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial","volume":"129","author":"Magalhaes","year":"2011","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0220","first-page":"1","article-title":"Peripheral oxidative damage in early-stage mood disorders: a nested population-based case\u2013control study","author":"Magalhaes","year":"2011","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.pnpbp.2011.11.011_bb0140","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jpsychires.2011.05.008","article-title":"Systemic toxicity in early-stage mood disorders","volume":"45","author":"Magalh\u00e3es","year":"2011","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0120","doi-asserted-by":"crossref","unstructured":"Magalhaes, P., Kapczinski, F., Nierenberg, A., Deckersbach, T., Weisinger, D., Dodd, S., Berk, M., (in press), Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder. Acta Psychiatrica Scandinavica.","DOI":"10.1111\/j.1600-0447.2011.01794.x"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0006-3223(03)00177-X","article-title":"Mood disorders and allostatic load","volume":"54","author":"McEwen","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0150","doi-asserted-by":"crossref","first-page":"4-4","DOI":"10.4088\/JCP.7075su1c.01","article-title":"Balancing the equation: managing comorbidities in patients with severe mental illness introduction","volume":"70","author":"McIntyre","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0155","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"New depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0160","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0447.2000.tb10933.x","article-title":"Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social funtioning","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2008.10.004","article-title":"N-acetylcysteine in high-sucrose diet-induced obesity: energy expenditure and metabolic shifting for cardiac health","volume":"59","author":"Novelli","year":"2009","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1601-5215.2008.00283.x","article-title":"Oxidative stress may be a common mechanism linking major depression and osteoporosis","volume":"20","author":"Pasco","year":"2008","journal-title":"Acta Neuropsychiatrica"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jad.2008.09.020","article-title":"A prospective study of the impact of comorbid medical disease on bipolar disorder outcomes","volume":"115","author":"Pirraglia","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/da.20521","article-title":"The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis?","volume":"26","author":"Soreca","year":"2009","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.06.006","article-title":"The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease","volume":"202","author":"Stephens","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2008.01204.x","article-title":"Weight gain in bipolar disorder: pharmacological treatment as a contributing factor","volume":"118","author":"Torrent","year":"2008","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pnpbp.2011.11.011_bb0195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"Rating-scale for mania \u2014 reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"The British Journal of Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584611003411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:33:53Z","timestamp":1640133233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584611003411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0278584611003411"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2011.11.011","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}